Pathway Medical Technologies Receives FDA Clearance For Jetstream(TM) Pathway PV(TM) Atherectomy System

�Pathway Medical Technologies, Inc., an groundbreaker of endovascular treatments for peripheral arterial disease (PAD), announced that the U.S. Food & Drug Administration (FDA) has given the company headroom to market place Jetstream(TM), a peripheral atherectomy catheter intentional for consumption in the treatment of PAD in the take down limbs. The clearance